2Q25 results show early signs of operational turnaround, with improved margins and lower OpEx, supporting my ongoing Buy rating for American Vanguard. Management sees the destocking cycle nearing its end, setting up for revenue and margin gains in 2H25 as inventory levels normalize. Operational leverage is materializing: modest revenue growth drove significant profitability gains, highlighting ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter ended June 30, 2025. Financial and Operational Highlights Second ...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE: AVD) announced today it will release financial results for the second quarter of 2025 on Thursday, July 31, 2025, after the market closes. The company will conduct a conference call focusing on operating performance and financial results at 5:00 p.m. ET / 2:00 p.m. PT on Thursday, July 31, 2025. The conference call wi...
AVD offers differentiated, branded agrochemicals with global distribution, but lacks patent protection and faces cyclical demand tied to corn prices. Recent operational challenges, including a major product recall and impairments, led to significant one-time losses, but normalized margins could yield $15–21 million in net income. Despite financial and regulatory risks, AVD's secular 5-6% growth...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard Corporation (NYSE:AVD) announced the voting results from its Annual Meeting of Stockholders held on July 2, 2025. As to the first of three initiatives, the nine director nominees named in the proxy received more votes “for” than “against”; those persons are: Marisol Angelini, Scott Baskin, Mark Bassett, Patrick Gottschalk, Emer Gunter, D...
American Vanguard Corporation is strategically positioned in the growing biopesticides market, benefiting from regulatory and consumer shifts away from conventional crop chemicals. Despite operational streamlining and improved working capital, Q1 2025 results revealed sharp revenue and margin declines due to aggressive pricing and regional setbacks. Financial and governance issues, including de...
American Vanguard Corporation (NYSE:AVD ) Q1 2025 Earnings Conference Call June 6, 2025 9:00 AM ET Company Participants Anthony Young - Director of Investor Relations David T. Johnson - Chief Financial Officer Douglas A.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.